Illumina's Numbers Without Roche

February 12, 2012

February 13, 2012 | Illumina has rejected Roche's most recent offer, and earlier in the week released fourth-quarter numbers that were a bit less than last year's, but still expected. Though Illumina's stock prices have fallen in the past six months, the company still feels that it is worth more than Roche has offered thus far. Motley Fool